<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04316884</url>
  </required_header>
  <id_info>
    <org_study_id>EPN 2017/043 Covid19</org_study_id>
    <nct_id>NCT04316884</nct_id>
  </id_info>
  <brief_title>Mechanisms for Organ Dysfunction in Covid-19</brief_title>
  <acronym>UMODCOVID19</acronym>
  <official_title>Uppsala Intensive Care Study of Mechanisms for Organ Dysfunction in Covid-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uppsala University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to investigate organ dysfunction and biomarkers in patients with suspected or&#xD;
      verified COVID-19 during intensive care at Uppsala University Hospital.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consenting patients with suspected or verified SARS-COV-2 infection, COVID-19, will undergo&#xD;
      daily blood, urine and sputum sampling during their stay in intensive care. Data on organ&#xD;
      dysfunction will be collected through the electronic patient journal and electronic patient&#xD;
      data management system. The collected samples will be analysed for a panel of potential&#xD;
      biomarkers that will be correlated to organ dysfunction and clinical outcome.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acute Kidney Injury</measure>
    <time_frame>During Intensive Care, an estimated average of 10 days.</time_frame>
    <description>KDIGO AKI score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ARDS</measure>
    <time_frame>During intensive care, an estimated average of 10 days.</time_frame>
    <description>Acute Respiratory Distress Syndrome yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 day mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Death within 30 days of ICU admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1 year mortality</measure>
    <time_frame>1 year</time_frame>
    <description>Death within 1 year of ICU admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic Kidney Disease</measure>
    <time_frame>60 days and 1 year after ICU admission</time_frame>
    <description>Development of Chronic Kidney Disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA-score</measure>
    <time_frame>During Intensive Care, an estimated average of 10 days.</time_frame>
    <description>Sequential Organ Failure Score as a continuous variable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thromboembolic events</measure>
    <time_frame>During intensive care</time_frame>
    <description>Occurence of thrombosis and/or embolous</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICUAW</measure>
    <time_frame>During intensive care or after intensive care</time_frame>
    <description>Intensive care acquired weakness</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>COVID-19</condition>
  <condition>Organ Dysfunction Syndrome Sepsis</condition>
  <condition>Organ Dysfunction Syndrome, Multiple</condition>
  <condition>Septic Shock</condition>
  <condition>Acute Kidney Injury</condition>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>COVID-19</arm_group_label>
    <description>Patients with suspected or verified COVID-19 admitted to intensive care at Uppsala University Hospital</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, Urine and Sputum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients requiring intensive care with suspected or verified COVID19&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admitted to intensive care&#xD;
&#xD;
          -  suspected or verified COVID-19&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or breastfeeding&#xD;
&#xD;
          -  Under-age&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Frithiof, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uppsala University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert Frithiof, MD. PhD.</last_name>
    <phone>0736563473</phone>
    <email>robert.frithiof@surgsci.uu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sara Bülow Anderberg, MD.</last_name>
    <phone>0730247414</phone>
    <email>sarabulow@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <zip>75185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Frithiof, MD. PhD.</last_name>
      <phone>073-6563473</phone>
      <email>robert.frithiof@surgsci.uu.se</email>
    </contact>
    <contact_backup>
      <last_name>Sara Bülow Anderberg, MD.</last_name>
      <phone>073-0247414</phone>
      <email>sarabulow@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Frithiof, MD. PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sara Bülow Anderberg, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Hultström, MD. PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miklos Lipcsey, MD. PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <results_reference>
    <citation>Hultström M, von Seth M, Frithiof R. Hyperreninemia and low total body water may contribute to acute kidney injury in COVID-19 patients in intensive care. J Hypertens. 2020 Aug;38(8):1613-1614. doi: 10.1097/HJH.0000000000002531.</citation>
    <PMID>32472780</PMID>
  </results_reference>
  <results_reference>
    <citation>Hultström M, Persson B, Eriksson O, Lipcsey M, Frithiof R, Nilsson B. Blood type A associates with critical COVID-19 and death in a Swedish cohort. Crit Care. 2020 Aug 12;24(1):496. doi: 10.1186/s13054-020-03223-8.</citation>
    <PMID>32787887</PMID>
  </results_reference>
  <results_reference>
    <citation>Eriksson O, Hultström M, Persson B, Lipcsey M, Ekdahl KN, Nilsson B, Frithiof R. Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients. Thromb Haemost. 2020 Dec;120(12):1720-1724. doi: 10.1055/s-0040-1715835. Epub 2020 Sep 1.</citation>
    <PMID>32871607</PMID>
  </results_reference>
  <results_reference>
    <citation>Stattin K, Lipcsey M, Andersson H, Pontén E, Bülow Anderberg S, Gradin A, Larsson A, Lubenow N, von Seth M, Rubertsson S, Hultström M, Frithiof R. Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients. J Crit Care. 2020 Dec;60:249-252. doi: 10.1016/j.jcrc.2020.08.026. Epub 2020 Sep 3.</citation>
    <PMID>32920503</PMID>
  </results_reference>
  <results_reference>
    <citation>Frithiof R, Bergqvist A, Järhult JD, Lipcsey M, Hultström M. Presence of SARS-CoV-2 in urine is rare and not associated with acute kidney injury in critically ill COVID-19 patients. Crit Care. 2020 Sep 29;24(1):587. doi: 10.1186/s13054-020-03302-w.</citation>
    <PMID>32993742</PMID>
  </results_reference>
  <results_reference>
    <citation>Asif S, Frithiof R, Lipcsey M, Kristensen B, Alving K, Hultström M. Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care. Crit Care. 2020 Nov 6;24(1):639. doi: 10.1186/s13054-020-03362-y.</citation>
    <PMID>33158455</PMID>
  </results_reference>
  <results_reference>
    <citation>Luther T, Bülow-Anderberg S, Larsson A, Rubertsson S, Lipcsey M, Frithiof R, Hultström M. COVID-19 patients in intensive care develop predominantly oliguric acute kidney injury. Acta Anaesthesiol Scand. 2021 Mar;65(3):364-372. doi: 10.1111/aas.13746. Epub 2020 Nov 28.</citation>
    <PMID>33190222</PMID>
  </results_reference>
  <results_reference>
    <citation>Bülow Anderberg S, Luther T, Berglund M, Larsson R, Rubertsson S, Lipcsey M, Larsson A, Frithiof R, Hultström M. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients. Cytokine. 2021 Feb;138:155389. doi: 10.1016/j.cyto.2020.155389. Epub 2020 Dec 14.</citation>
    <PMID>33348065</PMID>
  </results_reference>
  <results_reference>
    <citation>Zhou S, Butler-Laporte G, Nakanishi T, Morrison DR, Afilalo J, Afilalo M, Laurent L, Pietzner M, Kerrison N, Zhao K, Brunet-Ratnasingham E, Henry D, Kimchi N, Afrasiabi Z, Rezk N, Bouab M, Petitjean L, Guzman C, Xue X, Tselios C, Vulesevic B, Adeleye O, Abdullah T, Almamlouk N, Chen Y, Chassé M, Durand M, Paterson C, Normark J, Frithiof R, Lipcsey M, Hultström M, Greenwood CMT, Zeberg H, Langenberg C, Thysell E, Pollak M, Mooser V, Forgetta V, Kaufmann DE, Richards JB. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity. Nat Med. 2021 Apr;27(4):659-667. doi: 10.1038/s41591-021-01281-1. Epub 2021 Feb 25.</citation>
    <PMID>33633408</PMID>
  </results_reference>
  <results_reference>
    <citation>Lipcsey M, Persson B, Eriksson O, Blom AM, Fromell K, Hultström M, Huber-Lang M, Ekdahl KN, Frithiof R, Nilsson B. The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System. Front Immunol. 2021 Feb 22;12:627579. doi: 10.3389/fimmu.2021.627579. eCollection 2021.</citation>
    <PMID>33692801</PMID>
  </results_reference>
  <results_reference>
    <citation>Järhult JD, Hultström M, Bergqvist A, Frithiof R, Lipcsey M. The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients. Sci Rep. 2021 Mar 30;11(1):7163. doi: 10.1038/s41598-021-86500-y.</citation>
    <PMID>33785784</PMID>
  </results_reference>
  <results_reference>
    <citation>Frithiof R, Rostami E, Kumlien E, Virhammar J, Fällmar D, Hultström M, Lipcsey M, Ashton N, Blennow K, Zetterberg H, Punga AR. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study. Clin Neurophysiol. 2021 Jul;132(7):1733-1740. doi: 10.1016/j.clinph.2021.03.016. Epub 2021 Apr 1.</citation>
    <PMID>33875374</PMID>
  </results_reference>
  <results_reference>
    <citation>Galien S, Hultström M, Lipcsey M, Stattin K, Frithiof R, Rosén J; Uppsala Intensive Care COVID-19 Research Group. Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study. Thromb J. 2021 Jun 2;19(1):38. doi: 10.1186/s12959-021-00272-z.</citation>
    <PMID>34078399</PMID>
  </results_reference>
  <results_reference>
    <citation>Gradin A, Andersson H, Luther T, Anderberg SB, Rubertsson S, Lipcsey M, Åberg M, Larsson A, Frithiof R, Hultström M. Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients. Cytokine. 2021 Oct;146:155589. doi: 10.1016/j.cyto.2021.155589. Epub 2021 May 24.</citation>
    <PMID>34161857</PMID>
  </results_reference>
  <results_reference>
    <citation>Huckriede J, Anderberg SB, Morales A, de Vries F, Hultström M, Bergqvist A, Ortiz-Pérez JT, Sels JW, Wichapong K, Lipcsey M, van de Poll M, Larsson A, Luther T, Reutelingsperger C, de Frutos PG, Frithiof R, Nicolaes GAF. Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients. Sci Rep. 2021 Aug 3;11(1):15701. doi: 10.1038/s41598-021-95209-x.</citation>
    <PMID>34344929</PMID>
  </results_reference>
  <results_reference>
    <citation>Pellegrini M, Larina A, Mourtos E, Frithiof R, Lipcsey M, Hultström M, Segelsjö M, Hansen T, Perchiazzi G. A quantitative analysis of extension and distribution of lung injury in COVID-19: a prospective study based on chest computed tomography. Crit Care. 2021 Aug 4;25(1):276. doi: 10.1186/s13054-021-03685-4.</citation>
    <PMID>34348797</PMID>
  </results_reference>
  <results_reference>
    <citation>Karawajczyk M, Douhan Håkansson L, Lipcsey M, Hultström M, Pauksens K, Frithiof R, Larsson A. High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19. Ther Adv Infect Dis. 2021 Jul 31;8:20499361211034065. doi: 10.1177/20499361211034065. eCollection 2021 Jan-Dec.</citation>
    <PMID>34377464</PMID>
  </results_reference>
  <results_reference>
    <citation>Huckriede J, de Vries F, Hultström M, Wichapong K, Reutelingsperger C, Lipcsey M, Garcia de Frutos P, Frithiof R, Nicolaes GAF. Histone H3 Cleavage in Severe COVID-19 ICU Patients. Front Cell Infect Microbiol. 2021 Sep 10;11:694186. doi: 10.3389/fcimb.2021.694186. eCollection 2021.</citation>
    <PMID>34568088</PMID>
  </results_reference>
  <results_reference>
    <citation>Bülow Anderberg S, Lipcsey M, Hultström M, Eriksson AK, Venge P, Frithiof R, On Behalf Of The Uppsala Intensive Care Covid-Research Group. Systemic Human Neutrophil Lipocalin Associates with Severe Acute Kidney Injury in SARS-CoV-2 Pneumonia. J Clin Med. 2021 Sep 14;10(18). pii: 4144. doi: 10.3390/jcm10184144.</citation>
    <PMID>34575252</PMID>
  </results_reference>
  <results_reference>
    <citation>Sancho Ferrando E, Hanslin K, Hultström M, Larsson A, Frithiof R, Lipcsey M; Uppsala Intensive Care COVID-19 Research Group. Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study. Cytokine. 2021 Oct 5;149:155727. doi: 10.1016/j.cyto.2021.155727. [Epub ahead of print]</citation>
    <PMID>34628127</PMID>
  </results_reference>
  <results_reference>
    <citation>Nakanishi T, Pigazzini S, Degenhardt F, Cordioli M, Butler-Laporte G, Maya-Miles D, Bujanda L, Bouysran Y, Niemi ME, Palom A, Ellinghaus D, Khan A, Martínez-Bueno M, Rolker S, Amitrano S, Roade Tato L, Fava F, Spinner CD, Prati D, Bernardo D, Garcia F, Darcis G, Fernandez-Cadenas I, Holter JC, Banales JM, Frithiof R, Kiryluk K, Duga S, Asselta R, Pereira AC, Romero-Gómez M, Nafría-Jiménez B, Hov JR, Migeotte I, Renieri A, Planas AM, Ludwig KU, Buti M, Rahmouni S, Alarcón-Riquelme ME, Schulte EC, Franke A, Karlsen TH, Valenti L, Zeberg H, Richards JB, Ganna A. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. J Clin Invest. 2021 Oct 1. pii: e152386. doi: 10.1172/JCI152386. [Epub ahead of print]</citation>
    <PMID>34597274</PMID>
  </results_reference>
  <results_reference>
    <citation>COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. 2021 Jul 8. doi: 10.1038/s41586-021-03767-x. [Epub ahead of print]</citation>
    <PMID>34237774</PMID>
  </results_reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 13, 2020</study_first_submitted>
  <study_first_submitted_qc>March 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 20, 2020</study_first_posted>
  <last_update_submitted>October 17, 2021</last_update_submitted>
  <last_update_submitted_qc>October 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Uppsala University</investigator_affiliation>
    <investigator_full_name>Robert Frithiof</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Respiratory Distress Syndrome</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
    <mesh_term>Multiple Organ Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>IPD may be made available upon reasonable request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

